AspireAssist® Receives Endorsement by the American Society of Metabolic and Bariatric Surgeons
April 03, 2019 09:00 ET
|
Aspire Bariatrics
EXTON, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc. (“Aspire”), a commercial-stage medical device company, announced today that the American Society of the Metabolic and Bariatric...
AspireAssist® Demonstrates Significant Weight Loss through Four Years with Strong Safety Profile
February 05, 2018 12:15 ET
|
Aspire Bariatrics
KING OF PRUSSIA, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical device company, announced today the publication of 201-patient, multi-center post-market...
Aspire Bariatrics Announces Abstract Presentations at ObesityWeek 2017
November 01, 2017 12:28 ET
|
Aspire Bariatrics
KING OF PRUSSIA, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical device company, announced today two abstract presentations will be delivered on the...
Aspire Bariatrics Announces AspireAssist® Receives Australian TGA Approval and First Commercial Cases Performed in Australia
June 21, 2017 16:05 ET
|
Aspire Bariatrics
KING OF PRUSSIA, Pa., June 21, 2017 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical device company announced today that it received approval to market the AspireAssist®, a...
Aspire Bariatrics to Present at the 35th Annual JP Morgan Healthcare Conference
January 05, 2017 16:15 ET
|
Aspire Bariatrics
KING OF PRUSSIA, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical-device company with a novel device for the treatment of obesity, announced today that...
Aspire Bariatrics Announces Two-Year Observational Study Results Published in BMC Obesity for AspireAssist®
January 05, 2017 16:10 ET
|
Aspire Bariatrics
KING OF PRUSSIA, Pa., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Aspire Bariatrics, Inc., a commercial-stage medical-device company with a novel device for the treatment of obesity, announced today that the...